|
Volumn 46, Issue 3, 2002, Pages 863-865
|
Mutator bacteria as a risk factor in treatment of infectious diseases
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPICILLIN;
FOSFOMYCIN;
NALIDIXIC ACID;
RIFAMPICIN;
SPECTINOMYCIN;
STREPTOMYCIN;
ALLELE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL INFECTION;
BACTERIAL MUTATION;
CONTROLLED STUDY;
DISEASE MODEL;
DOSE TIME EFFECT RELATION;
DRUG SPECIFICITY;
GERMFREE ANIMAL;
GNOTOBIOTICS;
INFECTION RESISTANCE;
MOUSE;
MUTATION RATE;
MUTATOR GENE;
NONHUMAN;
PRIORITY JOURNAL;
PROBABILITY;
RISK FACTOR;
TREATMENT FAILURE;
ALLELES;
ANIMALS;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
COLONY COUNT, MICROBIAL;
DIGESTIVE SYSTEM;
DRUG RESISTANCE, MICROBIAL;
ESCHERICHIA COLI;
GERM-FREE LIFE;
MICE;
MICE, INBRED C3H;
MUTATION;
RISK FACTORS;
|
EID: 0036167884
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.3.863-865.2002 Document Type: Article |
Times cited : (81)
|
References (19)
|